BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36098326)

  • 1. Low testosterone concentrations and risk of ischaemic cardiovascular disease in ageing: not just a problem for older men.
    Heinze-Milne S; Banga S; Howlett SE
    Lancet Healthy Longev; 2022 Feb; 3(2):e83-e84. PubMed ID: 36098326
    [No Abstract]   [Full Text] [Related]  

  • 2. Testosterone and cardiovascular disease risk.
    Yeap BB
    Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):193-202. PubMed ID: 25887389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens and cardiovascular disease.
    Yeap BB
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):269-76. PubMed ID: 20186051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative Stress and Inflammation Are Associated With Age-Related Endothelial Dysfunction in Men With Low Testosterone.
    Babcock MC; DuBose LE; Witten TL; Stauffer BL; Hildreth KL; Schwartz RS; Kohrt WM; Moreau KL
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e500-e514. PubMed ID: 34597384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgens and the ageing male.
    Swerdloff RS; Wang C
    Best Pract Res Clin Endocrinol Metab; 2004 Sep; 18(3):349-62. PubMed ID: 15261842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen activity, ischaemic heart disease and risk factors among men in NHANES III.
    Schooling CM
    Eur J Clin Invest; 2013 Dec; 43(12):1273-81. PubMed ID: 24117250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone and ill-health in aging men.
    Yeap BB
    Nat Clin Pract Endocrinol Metab; 2009 Feb; 5(2):113-21. PubMed ID: 19165223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversial Effects of Exogenous Testosterone on Cardiovascular Diseases.
    Al-Khazaali A; Arora R; Muttar S
    Am J Ther; 2016; 23(6):e1504-e1513. PubMed ID: 25719442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Androgen Concentrations and Risk of Incident Heart Failure in Older Men: The Cardiovascular Health Study.
    Njoroge JN; Tressel W; Biggs ML; Matsumoto AM; Smith NL; Rosenberg E; Hirsch CH; Gottdiener JS; Mukamal KJ; Kizer JR
    J Am Heart Assoc; 2022 Nov; 11(21):e026953. PubMed ID: 36285783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased occurrence of marked elevations of lipoprotein(a) in ageing, hypercholesterolaemic men with low testosterone.
    Kaplan SA; Lin J; Johnson-Levonas AO; Shah AK; Meehan AG
    Aging Male; 2010 Mar; 13(1):40-3. PubMed ID: 20059436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline of guidelines: testosterone therapy for testosterone deficiency.
    Salter CA; Mulhall JP
    BJU Int; 2019 Nov; 124(5):722-729. PubMed ID: 31420972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Testosterone deficiency in the ageing male].
    Jaschke NP; Rachner TD; Hofbauer LC
    Dtsch Med Wochenschr; 2021 Feb; 146(3):141-145. PubMed ID: 33513645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone Threshold for Increased Cardiovascular Risk in Middle-Aged and Elderly Men: A Locally Weighted Regression Analysis.
    Liao PW; Wu CC; Chen KC; Jaw FS; Yu HJ; Liu SP; Ho CH
    J Sex Med; 2016 Dec; 13(12):1872-1880. PubMed ID: 27843074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically predicted testosterone and cardiovascular risk factors in men: a Mendelian randomization analysis in the Guangzhou Biobank Cohort Study.
    Zhao J; Jiang C; Lam TH; Liu B; Cheng KK; Xu L; Au Yeung SL; Zhang W; Leung GM; Schooling CM
    Int J Epidemiol; 2014 Feb; 43(1):140-8. PubMed ID: 24302542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease.
    Boden WE; Miller MG; McBride R; Harvey C; Snabes MC; Schmidt J; McGovern ME; Fleg JL; Desvigne-Nickens P; Anderson T; Kashyap M; Probstfield JL
    Am Heart J; 2020 Jun; 224():65-76. PubMed ID: 32335402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of androgens on the cardiovascular system.
    Rosano GM; Cornoldi A; Fini M
    J Endocrinol Invest; 2005; 28(3 Suppl):32-8. PubMed ID: 16042358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone, aging and survival: biomarker or deficiency.
    Shores MM; Matsumoto AM
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):209-16. PubMed ID: 24722173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men.
    Yeap BB
    Asian J Androl; 2018; 20(2):109-114. PubMed ID: 29199649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health Outcomes Among Long-term Opioid Users With Testosterone Prescription in the Veterans Health Administration.
    Jasuja GK; Ameli O; Reisman JI; Rose AJ; Miller DR; Berlowitz DR; Bhasin S
    JAMA Netw Open; 2019 Dec; 2(12):e1917141. PubMed ID: 31825502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone deficiency: a risk factor for cardiovascular disease?
    Jones TH
    Trends Endocrinol Metab; 2010 Aug; 21(8):496-503. PubMed ID: 20381374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.